Abstract
Infective endocarditis (IE) is a life-threatening infection that is invariably lethal without intensive antibacterial treatment. Wide array of microorganisms has been encountered as causative agents of infection with streptococci (viridans streptococci) and staphylococci being the most common. Other bacteria, fungi, chlamydiae, rickettsiae, etc. are less frequently responsible for IE. The cornerstone of successful therapy is a prolonged parenteral treatment with high doses of appropriate bactericidal antibiotics. We review published recommendations for antimicrobial treatment of IE caused by specific microorganisms depending on their antibiotic susceptibility and empiric antibacterial treatment of IE with unknown etiology as well. Short regimens of antibiotic therapy will be also discussed.
-
1.
Conterno L.О., Wey S.B., Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
-
2.
Frimoedt-Moller N., Esperson F., Skinhoj P., et al. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3:297-305.
-
3.
Jonson A.P., James D. Continuing increase in invasive methiсillin-resistant Staphylococcus aureus infection. Lancet 1997; 350:1710.
-
4.
Speller D.C.E., Jonson A.P., James D., et al. Resistance to methicillin and other antibiotics in Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–1995. Lancet 1997; 350:323-5.
-
5.
Pfaller M.A., Jones R.N., Marchall S.A., et al. Nosocomial streptococcal blood stream infections in the SCOPE program: species occurrence and antimicrobial resistance. Diagn Microbol Infect Dis 1997; 29:259-63.
-
6.
Martinez L.M., Lopes-Hernandez I., Pascual A., et al. Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain. Clin Microbiol Infect 1997; 3:382-5.
-
7.
Benetka O., Block M., Sangha O., et al. Clinical course of infective endocarditis in the late nineties: preliminary results of the ALKK endocarditis registry. Proceedings of the XXI Congress of the European Society of Cardiology; 1999; Barcelona, Spain.
-
8.
Wilson W.R., Karchmer A.W., Dajani A.S., et al. Antibiotic treatment of adult with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995; 274:1706-13.
-
9.
Francioli P., Ruch W., Stamboulian D., and the International infective endocarditis study group. Treatment of Streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study. Clin Infect Dis 1995; 21:1406-10.
-
10.
Horn D.L., Zabriskie J.B. Why have group А streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998; 26:1341-5.
-
11.
Нadjinikolaou L., Stamou S.H., Rizos I., et al. Brucella infective endocarditis: successful combination of medical and surgical treatment. Proceedings of the XXI Congress of the European Society of Cardiology; 1999; Barcelona, Spain. p.2922.
-
12.
Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998; 338:520-32.
-
13.
Демин А.А., Дробышева В.П. Короткие курсы антибактериальной химиотерапии стафилококкового эндокардита. Тез. докл. VI Рос. нац. конгресс "Человек и лекарство"; 1999. с.150.
-
14.
Francioli P., Ruch W., Stamboulian D., and the International infective endocarditis study group. Treatment of Streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study. Clin Infect Dis 1995; 21:1406-10.
-
15.
Simmons N.A., Ball A.P., Eykyn S.J., et al. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 1998; 79:207-10.
-
16.
Barza M., Ioannidis J.P.A., Cappelleri J.C., Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. Br Med J 1996; 312:338-45.
-
17.
Chambers H.F. Short-course combination and oral therapies of Staphylococcus aureus endocarditis. Med Clin North Am 1993; 7:69-80.
-
18.
Torres-Tortosa M., de Cuesto M., Vergara A., et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Eur J Clin Microbiol Infect Dis 1994; 13:559-64.
-
19.
Oakley C.M. The medical treatment of culture-negative infective endocarditis. Eur Heart J 1995; 16 (Suppl B):90-3.
-
20.
Delahaye F., Goulet V., Lacassin F., et al. Incidence, caracteristiques demographiques, cliniques, microbiologiques et evolutives de l'endocardite infectieuse en France en 1990-91. Med Mal Infect 1992; 22:975-86.
-
21.
De Man F., Peetermans W.E., Van de Werf F. Changing pattern of etiologic microorganisms in infective endocarditis: comparison of a retrospective study in the 80s and a prospective study in the 90s. Proceedings of the XIXth Congress of the European Society of Cardiology; 1997; Stockholm, Sweden. p. 2046.
-
22.
Kupferwasser I., Darius H., Muller A.M., et al. Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart 1998; 80:276-80.
-
23.
Selton-Suty C., Hoen B., Grentzinger A., et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 1997; 77:260-3.
-
24.
Siddiq S., Missri J., Silverman D.I. Endocarditis in an urban hospital in the 1990s. Arch Intern Med 1996; 156:2454-8.